Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Interleukin-1 Receptor Antagonist (IL-1RA) Mediates Age-Dependent Immunoregulation of Adipose-Derived Stem Cells via Macrophage Polarization.

Dong Q., Zhu Y., Xu S., Li D., Wu Q.

Animal Study on Immune Modulation, published in Cells (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Cells (2026)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
42587765
DOI
10.3390/cells15151355

Abstract (original English)

This study aimed to clarify whether interleukin-1 receptor antagonist (IL-1RA) mediates the age-dependent immunomodulatory capacity of adipose-derived stem cells (ASCs) via regulating macrophage polarization. ASCs from young (Y-ASCs) and aged (O-ASCs) C57BL/6 mice were isolated. IL-1RA, which was identified as an age-sensitive candidate through integrated transcriptomic and proteomic screening in our prior publication, was validated by qPCR, immunofluorescence, and ELISA. RAW264.7 macrophages were polarized and co-cultured with ASCs or treated with recombinant IL-1RA; IL-1RA in Y-ASCs was silenced by siRNA (82.3 ± 5.1% knockdown efficiency). The results showed Y-ASCs had 2.1-fold higher IL-1RA mRNA and significantly higher protein secretion than O-ASCs ( p < 0.001). Y-ASC transplantation enhanced M2 polarization (CD206 + cells increased from 9.36% to 21.4% in vivo; p < 0.01) in aged mouse adipose tissue and reduced inflammation (serum IL-1β lowered by 42.3 ± 5.1%; p < 0.001), while O-ASCs had no effect. Recombinant IL-1RA recapitulated Y-ASC effects (M2 macrophages increased from 0.92% to 61.8%; p < 0.001), and IL-1RA silencing abrogated Y-ASC function. The data indicate IL-1RA is a key age-sensitive mediator of ASC immunomodulation. Declined IL-1RA may contribute to impaired aged ASC efficacy, highlighting donor age's importance. This provides mechanistic insights and guides I

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMacrophagesMiceAdipose TissueMice, Inbred C57BLInterleukin 1 Receptor Antagonist ProteinStem CellsRAW 264.7 CellsAgingCell Polarity

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research